Skip to main content

Table 3 Group classifications and doses used in the 4-day suppressive test

From: Preclinical evaluation of antimalarial activity of CPF-1 formulation as an alternative choice for the treatment of malaria

Groups (n = 5/group)

Extract/drug

Dose (mg/kg)

Negative control

7% Tween 80

-

Positive control

Artesunate

6

Positive control

Chloroquine

25

Experimental group 1

Ethanolic extract of formulation 1

200

Experimental group 2

Ethanolic extract of formulation 1

400

Experimental group 3

Ethanolic extract of formulation 1

600